STEM
David Faulkner has extensive work experience in the healthcare industry. David began their career at The Wellcome Foundation Limited in 1987, where they held various sales and managerial roles in the Arabian Gulf, Jordan, Cyprus, and Lebanon. David then joined Eli Lilly in 1996, contributing to corporate strategy in infectious diseases and cardiovascular health. David continued their tenure at Eli Lilly until 2003, with roles in regional marketing and planning and analysis management. David joined Johnson & Johnson in 2006 as a regional managing director in the Middle East before moving to Shire in 2011 as a senior director in global market development. In 2013, they joined Smith & Nephew as a vice president in strategic marketing for emerging markets. Most recently, David served as a senior vice president at STEM Healthcare, where they held several leadership positions, including global client relations and regional managing director responsibilities for Turkey, the Middle East, and Latin America.
David Faulkner attended St Joseph's College in Ipswich from 1970 to 1980. David then went on to study Economics at the University of Nottingham from 1980 to 1983, earning a Bachelor of Arts (Hons) degree.
STEM
STEM is part of Inizio Advisory, a trusted advisor for pharmaceutical, life science and healthcare companies at every stage of the product and patient journey. Through Advisory’s data driven approach and connected intelligence and solutions, Inizio Advisory helps accelerate clinical and commercial success, creating long term value for clients and their patients. Since 2007, STEM has been helping life science companies optimize the commercial performance by measuring the alignment between their brand strategy and execution at every stage of the product stage of the product lifecycle. We do this through our objective industry insights, robust benchmarking data, and a proven methodology, helping clients to improve return on investment, drive greater customer engagement, accelerate their brands performance and ensure world-class medicines reach the right patients.